Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Oncotarget|September 23, 2016
Somatic polyploidy is associated with the upregulation of c-MYC interacting genes and EMT-like signatureAlejandro Vazquez-Martin, Olga V Anatskaya, Alessandro Giuliani, et al.
International Journal of Oncology|November 4, 2009
Fatty acid synthase activity regulates HER2 extracellular domain shedding into the circulation of HER2-positive metastatic breast cancer patientsAlejandro Vazquez-Martin, Jose Manuel Fernandez-Real, Cristina Oliveras-Ferraros, et al.
Autophagy|March 15, 2013
Autophagy in stem cellsJun-Lin Guan, Anna Katharina Simon, Mark Prescott, et al.
Scientific Reports|August 23, 2013
The anti-malarial chloroquine overcomes primary resistance and restores sensitivity to trastuzumab in HER2-positive breast cancerSílvia Cufí, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, et al.
Cell Cycle (Georgetown, Tex.)|June 24, 2015
Role of stress-activated OCT4A in the cell fate decisions of embryonal carcinoma cells treated with etoposideAnda Huna, Kristine Salmina, Jekaterina Erenpreisa, et al.
Cell Cycle (Georgetown, Tex.)|February 21, 2014
Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profileCristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Elisabet Cuyàs, et al.
Journal of Cellular Biochemistry|November 25, 2010
Stem cell property epithelial-to-mesenchymal transition is a core transcriptional network for predicting cetuximab (Erbitux™) efficacy in KRAS wild-type tumor cellsCristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Sílvia Cufí, et al.
Cell Cycle (Georgetown, Tex.)|September 21, 2012
Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin)Cristina Oliveras-Ferraros, Bruna Corominas-Faja, Sílvia Cufí, et al.
Cell Cycle (Georgetown, Tex.)|April 4, 2013
The Warburg effect version 2.0: metabolic reprogramming of cancer stem cellsJavier A Menendez, Jorge Joven, Sílvia Cufí, et al.
Cell Cycle (Georgetown, Tex.)|October 11, 2013
Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cellsAlejandro Vazquez-Martin, Sílvia Cufí, Eugeni López-Bonet, et al.
Pageof 8